# Pharmacokinetics of Irbesartan High/Amlodipine FDC and Co-administration of Irbesartan High and Amlodipine in Healthy Volunteers

> **NCT05688085** · PHASE1 · COMPLETED · sponsor: **Handok Inc.** · enrollment: 44 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Irbesartan High/Amlodipine FDC
- **DRUG:** Irbesartan High
- **DRUG:** Amlodipine

## Key facts

- **NCT ID:** NCT05688085
- **Lead sponsor:** Handok Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-18
- **Primary completion:** 2022-12-29
- **Final completion:** 2023-04-21
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2023-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05688085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05688085, "Pharmacokinetics of Irbesartan High/Amlodipine FDC and Co-administration of Irbesartan High and Amlodipine in Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05688085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*